Holmium 166 Chloride Market
Holmium 166 Chloride Market
The market for Holmium 166 Chloride was estimated at $360.40 million in 2024; it is anticipated to increase to $525 million by 2030, with projections indicating growth to around $720 million by 2035.
Global Holmium 166 Chloride Market Outlook
Revenue, 2024 (US$M)
Forecast, 2034 (US$M)
CAGR, 2024 - 2034
Market Key Insights
- The Holmium 166 Chloride market is projected to grow from $360.4 million in 2024 to $676 million in 2034. This represents a CAGR of 6.5%, reflecting rising demand across Radiation Therapy, Arthritic Treatment and Medical Imaging.
- Bayer AG, Carthera SAS, Eckert & Ziegler AG are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Holmium 166 Chloride market and are expected to observe the growth CAGR of 4.2% to 6.2% between 2024 and 2030.
- Emerging markets including Iran, Brazil and Canada are expected to observe highest growth with CAGR ranging between 7.5% to 9.0%.
- Transition like Move towards Theranostics is expected to add $45.3 million to the Holmium 166 Chloride market growth by 2030
- The Holmium 166 Chloride market is set to add $316 million between 2024 and 2034, with manufacturer targeting Research Use & Industrial Use Application projected to gain a larger market share.
- With Increasing use in radiotherapy, and Advancement in medical imaging, Holmium 166 Chloride market to expand 88% between 2024 and 2034.
Opportunities in the Holmium 166 Chloride
The progress in technology has transformed sectors significantly including the field of Holmium 166 chloride. Developments in medical imaging technologies and radiographic methods have increased the need for products like Holmium 166 chloride contributing significantly to their market growth. The changing market preference towards sophisticated methods indicates promising prospects, for Holmium 166 chloride.
Growth Opportunities in North America and Europe
North America Outlook
Europe Outlook
Market Dynamics and Supply Chain
Driver: Increasing Use in Radiotherapy, and Expansion in Nuclear Medicine
Restraint: Limited Production Capabilities
Opportunity: Strategic Collaborations for Global Market Expansion and Expanding Therapeutic Applications
Challenge: Stringent Regulatory Compliance
Supply Chain Landscape
Holmium mines China Rare Metals and Rare Earth
Gansu Rare Earth New Material
Areva
Solvay Group
Health Physics Society
Curium Pharma
Medical Imaging
Cancer Therapeutics
Nuclear Medicine
Holmium mines China Rare Metals and Rare Earth
Gansu Rare Earth New Material
Areva
Solvay Group
Health Physics Society
Curium Pharma
Medical Imaging
Cancer Therapeutics
Nuclear Medicine